Effect of Canakinumab on Survival in Patients Hospitalized With Severe COVID-19

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JULY 20, 2021

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.9508?guestAccessKey=c28bd7c9-2c8e-4715-81c9-c6da6520b166&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072021

 

Visual Abstract

 

Authors: Roberto Caricchio, M.D., of the Lewis Katz School of Medicine at Temple University in Philadelphia, is the corresponding author.

(doi:10.1001/jama.2021.9508)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.